jnis.bmj11d
Antithrombotic resumption after middle meningeal artery embolization or surgery for chronic subdural hematoma: a systematic review and meta-analysis
Background The periprocedural management of antithrombotic medications in patients with chronic subdural hematoma (cSDH) after middle meningeal artery embolization (MMAE) or surgical evacuation is ...
jnis.bmj2d
Update on cerebral hyperperfusion syndrome
Correspondence to Professor Hon-Man Liu, Medical Imaging, National Taiwan University Hospital, Taipei 10016, Taiwan; hmliu{at}ntu.edu.tw Cerebral hyperperfusion syndrome (CHS) is a clinical syndrome ...
jnis.bmj3d
Transarterial and transvenous access for neurointerventional surgery: report of the SNIS Standards and Guidelines Committee
Correspondence to Dr Justin F Fraser, Neurological Surgery, University of Kentucky, Lexington, KY 40536, USA; Jfr235{at}uky.edu ...
jnis.bmj6d
Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting
Introduction Although venous sinus stenting (VSS) has emerged as a promising treatment option for patients with idiopathic intracranial hypertension (IIH) and associated venous sinus stenosis, there ...
jnis.bmj9d
Futile reperfusion of endovascular treatment for acute anterior circulation large vessel occlusion in the ANGEL-ACT registry
Correspondence to Dr Zhongrong Miao, Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China; zhongrongm{at}163.com; Dr Xiaochuan Huo, ...
jnis.bmj3d
Early neurologic decline in acute ischemic stroke patients receiving thrombolysis with large vessel occlusion and mild deficits
Correspondence to Dr Vivien H Lee, Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; vivien.lee{at}osumc.edu Background We sought to determine the rate of early ...
jnis.bmj3d
Online First
The River study: the first prospective multicenter trial of a novel venous sinus stent for the treatment of idiopathic intracranial hypertension ...
jnis.bmj4d
Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology
Background The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to ...
jnis.bmj9d
Tmax >4 s volume predicts stroke recurrence in symptomatic intracranial atherosclerotic stenosis with optimal medical treatment
Background The time to maximum (Tmax) profile based on computed tomography perfusion (CTP) provides a quantitative assessment of cerebral hemodynamic compromise. We aimed to delineate the Tmax profile ...
jnis.bmj9d
Effects of different endovascular treatments on cerebral perfusion changes and stroke recurrence in patients with intracranial atherosclerosis
Background In patients with refractory intracranial atherosclerotic disease (ICAD), percutaneous transluminal balloon angioplasty (PTBA) is less complex but typically results in higher postprocedural ...
jnis.bmj3d
A prospective study of the transradial approach for diagnostic cerebral arteriography
Background The transradial approach for cardiac catheterization is associated with improved patient safety and satisfaction in comparison with the transfemoral approach. Prospective data for the ...
jnis.bmj8d
Braid stability after flow diverter treatment of intracranial aneurysms: a systematic review and meta-analysis
Background The aim of this study was to evaluate the overall rates of braid changes associated with flow diverter (FD) treatment for intracranial aneurysms (IAs). Additionally, we sought to provide an ...